| (-)-Thyroxine |
| (125I)T4 |
| (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid |
| (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid |
| (S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid |
| 002T595 |
| 1373931-44-2 |
| 1hk1 |
| 1hk2 |
| 1hk3 |
| 1hk4 |
| 1hk5 |
| 1y0x |
| 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid |
| 24486-40-6 |
| 2ceo |
| 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine |
| 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine |
| 3,3',5,5'-Tetraiodo-L-thyronine |
| 3,3',5,5''-Tetraiodo-L-thyronine |
| 3,3'',5,5''-tetraiodo-L-thyronine |
| 3,5,3',5'-Tetraiodo-L-thyronine |
| 3,5,3',5'-Tetraiodothyronine |
| 3,5,3'',5''-tetraiodo-L-thyronine |
| 3,5,3'5'-Tetraiodo-L-thyronine |
| 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine |
| 51-48-9 |
| 587-29-1 |
| 587-30-4 |
| 60833-83-2 |
| 7200-84-2 |
| 74-16-8 |
| 7U4LEE5872 |
| AB00052176_09 |
| AB00052176_10 |
| AB00052176-08 |
| AB0010528 |
| AB2000689 |
| AC-10465 |
| AC-7504 |
| AC1L1L7K |
| AK-40208 |
| AKOS015905129 |
| AM83594 |
| AN-15421 |
| AN-8921 |
| AX8015809 |
| BC630681 |
| BDBM50301375 |
| beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine |
| BIDD:PXR0161 |
| bmse000923 |
| BPBio1_000360 |
| BRD-K30685142-001-05-5 |
| BRD-K30685142-001-08-9 |
| BRN 2228515 |
| BSPBio_000326 |
| BSPBio_002142 |
| C01829 |
| C15H11I4NO4 |
| CAS-51-48-9 |
| CCG-38738 |
| CCRIS 6739 |
| CHEBI:18332 |
| CHEMBL1624 |
| CHM0030272 |
| CPD000059176 |
| CS-1819 |
| CT-230 |
| CTK2H7538 |
| D08125 |
| DB-006261 |
| DB00451 |
| DivK1c_006967 |
| DL-Thyroxin |
| DSSTox_CID_3214 |
| DSSTox_GSID_23214 |
| DSSTox_RID_76927 |
| DTXSID8023214 |
| EINECS 200-101-1 |
| eltroxin |
| Epitope ID:123889 |
| Eutirox |
| Forthyron (TN) |
| FT-0600821 |
| GP9966 |
| GTPL2635 |
| Henning |
| HMS1569A08 |
| HMS1921I06 |
| HMS2090P18 |
| HMS2092K12 |
| HMS2096A08 |
| HMS2233J18 |
| HMS3259M11 |
| HMS3713A08 |
| HSDB 3108 |
| HY-18341 |
| J10324 |
| KB-53412 |
| KBio1_001911 |
| KBio2_001556 |
| KBio2_004124 |
| KBio2_006692 |
| KBio3_001642 |
| KBioGR_000516 |
| KBioSS_001556 |
| KS-00000HDI |
| L-3,5,3',5'-Tetraiodothyronine |
| L-T4 |
| L-Thryoxin |
| L-Thyroxin |
| L-thyroxine |
| L-Thyroxine (T4) solution, 100 mug/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material |
| L-Thyroxine, >=98% (HPLC) |
| L-Thyroxine, 97+% |
| L-Thyroxine, free acid |
| L-Thyroxine, powder, BioReagent, suitable for cell culture |
| L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo- |
| Laevothyroxinum |
| Laevothyroxinum (acid) |
| levothroid |
| Levothroid (*Sodium salt*) |
| Levothyroxin |
| levothyroxine |
| Levothyroxine (BAN) |
| Levothyroxine [INN:BAN] |
| Levothyroxine sodium |
| Levothyroxine Sodium (L-thyroxine) |
| Levothyroxine, Pharmaceutical Secondary Standard; Certified Reference Material |
| Levothyroxine, United States Pharmacopeia (USP) Reference Standard |
| Levothyroxinum |
| Levothyroxinum (acid) |
| LS-158291 |
| LT4 |
| MFCD00002595 |
| MLS000028647 |
| MLS002548901 |
| MolPort-003-666-820 |
| NC00485 |
| NCGC00094852-03 |
| NCGC00164336-01 |
| NCGC00164336-02 |
| NCGC00164336-03 |
| NCGC00164336-05 |
| NCGC00164336-06 |
| NCGC00255368-01 |
| NSC 36397 |
| NSC-757434 |
| NSC757434 |
| O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine |
| O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine |
| O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine |
| Pharmakon1600-01500774 |
| Prestwick_548 |
| Prestwick0_000403 |
| Prestwick1_000403 |
| Prestwick2_000403 |
| Prestwick3_000403 |
| Q51BO43MG4 |
| s2599 |
| SAM002264651 |
| SBI-0051608.P002 |
| SCHEMBL23098 |
| SDCCGMLS-0066571.P001 |
| SMR000059176 |
| SPBio_000386 |
| SPBio_002265 |
| SpecPlus_000871 |
| Spectrum_001076 |
| SPECTRUM1500774 |
| Spectrum2_000573 |
| Spectrum3_000611 |
| Spectrum4_000128 |
| Spectrum5_001500 |
| SR-01000759430 |
| SR-01000759430-2 |
| SR-05000001567 |
| SR-05000001567-1 |
| ST24047479 |
| SW196731-3 |
| synthroid |
| Synthroid (*Sodium salt*) |
| Synthroid sodium |
| T-3850 |
| t4 |
| T4 (Hormone) |
| T4 levothyroxine |
| T44 |
| Tetraiodothyronine |
| Tetramet |
| Thryroxine, l- |
| THX |
| Thyratabs |
| Thyrax |
| Thyreoideum |
| thyroxin |
| Thyroxinal |
| thyroxine |
| Thyroxine (l) |
| Thyroxine (T4), IRMM(R) certified Reference Material |
| Thyroxine (VAN) |
| Thyroxine [BAN] |
| Thyroxine I 125 |
| Thyroxine iodine |
| Thyroxine, L- |
| Thyroxine, L- (8CI) |
| Thyroxine, labeled with iodine-125 |
| Tox21_112101 |
| Tox21_112101_1 |
| Tox21_302156 |
| TR-031344 |
| Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125 |
| UNII-7U4LEE5872 |
| UNII-Q51BO43MG4 |
| UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-LBPRGKRZSA-N |
| XUIIKFGFIJCVMT-LBPRGKRZSA-N |
| ZINC3830993 |
